Title:
NOVEL COMPOSITION FOR TREATING CANCER
Document Type and Number:
WIPO Patent Application WO/2019/066536
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for treating cancer. The present invention provides a pharmaceutical composition for treating cancer, comprising as active ingredients: signal-regulatory proteins or fusion proteins including the signal-regulatory proteins; multimers of the fusion proteins including multimerization domains; and an immunogenic cell death inducer.
Inventors:
KIM YOON KYOUNG (KR)
NAM GIHOON (KR)
YANG YOO SOO (KR)
KIM IN-SAN (KR)
NAM GIHOON (KR)
YANG YOO SOO (KR)
KIM IN-SAN (KR)
Application Number:
PCT/KR2018/011505
Publication Date:
April 04, 2019
Filing Date:
September 28, 2018
Export Citation:
Assignee:
KOREA INST SCI & TECH (KR)
International Classes:
A61K31/337; A61K38/16; A61K31/704; A61K39/395; A61K45/06
Foreign References:
| US20160340397A1 | 2016-11-24 | |||
| US20150329616A1 | 2015-11-19 | |||
| KR20170036796A | 2017-04-03 | |||
| KR20160132117A | 2016-11-16 |
Other References:
LEE, N. K. ET AL.: "Ferritin Nanocage with Intrinsically Disordered Proteins and Affibody: A Platform for Tumor Targeting with Extended Pharmacokinetics", JOURNAL OF CONTROLLED RELEASE, vol. 267, 15 August 2017 (2017-08-15), pages 172 - 180, XP085290880, DOI: doi:10.1016/j.jconrel.2017.08.014
Attorney, Agent or Firm:
HAN, Yun Ho (KR)
Download PDF: